Strive, Inc. Variable Rate Series A Perpetual Preferred Stock

Strive, Inc. Variable Rate Series A Perpetual Preferred Stock (SATA) Financials

$97.770

+1.134 (+1.16%)At close

SATA Profitability and Margins

Evaluating the bottom line, Strive, Inc. Variable Rate Series A Perpetual Preferred Stock maintains a gross margin of -454.71%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -729.51%, while the net margin is -8759.03%. These profitability ratios, combined with a Return on Equity (ROE) of -170.21%, provide a clear picture of how effectively SATA converts its operational activities into shareholder value.

Strive, Inc. Variable Rate Series A Perpetual Preferred Stock Financial Performance

Lisata Therapeutics has shown poor financial performance with a net income loss of -$4,489,000 in Q1 2026 and a year-to-date change of -47.96%. The gross margin fluctuates significantly, indicating instability in revenue generation.

Financials

FY2026Q2
YoY:
+94.72%
2.94M
Total Revenue
FY2026Q2
YoY:
+481.31%
-21.45M
Operating Profit
FY2026Q2
YoY:
+2802.66%
-257.60M
Net Income after Tax
FY2026Q2
YoY:
-212.66%
-22.41M
Free Cash Flow
FY2026Q2
YoY:
+229.98%
-454.71
Gross Profit Margin - %
FY2026Q2
-1.07K
FCF Margin - %
FY2026Q2
YoY:
+1390.67%
-8.76K
Net Margin - %
FY2026Q2
-165.40
ROIC

Related articles

This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.

Start trading